John H. Parrish

Co-Founder & CEO

Vital Metrics; Intramed; ISTA Pharmaceuticals; Angiosyn; BioVascular; 5 start-ups, 3 IPO’s, 3 sales to large companies

• Private and public equity investment experience
• Clinical trials execution, US and ex-US
• Repeat Entrepreneur/CEO, Start-up through public IPO and commercialization
• Successful Regulatory (US FDA and ex-US Regulators) experience

Paul F. Glidden, PhD

Co-founder & VP Development

Alpha Therapeutics; ISTA Pharmaceuticals; Angiosyn; BioVascular; NanoSmart Pharmaceuticals

• Successfully developed multiple novel compounds, successfully patented IP
• Small molecule, biologic, biotech and nanoparticle production systems
• cGMP production experience, R&D through commercialization
• QA/QC audit and FDA facilities (PAI) inspection experience,
• Clinical trials design, submission, execution and analyses, cGCP, US and ex-US
• Non-clinical & pre-clinical trials design, execution and analyses, cGLP
• Successful Regulatory US FDA and ex-US Regulatory experience

Merle W. Richman, Esq

Co-founder, General Counsel

• Seasoned patent attorney in the medical industry
• Successfully prosecuted drug and device patent applications, US and ex-US